240 related articles for article (PubMed ID: 20485912)
1. Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.
Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):220-6. PubMed ID: 20485912
[TBL] [Abstract][Full Text] [Related]
2. Therapy of hypoparathyroidism with intact parathyroid hormone.
Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
[TBL] [Abstract][Full Text] [Related]
5. Mini-review: new therapeutic options in hypoparathyroidism.
Cusano NE; Rubin MR; Sliney J; Bilezikian JP
Endocrine; 2012 Jun; 41(3):410-4. PubMed ID: 22311174
[TBL] [Abstract][Full Text] [Related]
6. Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.
Cusano NE; Rubin MR; McMahon DJ; Zhang C; Ives R; Tulley A; Sliney J; Cremers SC; Bilezikian JP
J Clin Endocrinol Metab; 2013 Jan; 98(1):137-44. PubMed ID: 23162103
[TBL] [Abstract][Full Text] [Related]
7. Management of Hypoparathyroidism: Present and Future.
Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP
J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Manifestations of Hypoparathyroidism.
Rubin MR
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):825-837. PubMed ID: 30390816
[TBL] [Abstract][Full Text] [Related]
10. Use of parathyroid hormone in hypoparathyroidism.
Cusano NE; Rubin MR; Irani D; Sliney J; Bilezikian JP
J Endocrinol Invest; 2013 Dec; 36(11):1121-7. PubMed ID: 24445125
[TBL] [Abstract][Full Text] [Related]
11. PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.
Rubin MR; Dempster DW; Sliney J; Zhou H; Nickolas TL; Stein EM; Dworakowski E; Dellabadia M; Ives R; McMahon DJ; Zhang C; Silverberg SJ; Shane E; Cremers S; Bilezikian JP
J Bone Miner Res; 2011 Nov; 26(11):2727-36. PubMed ID: 21735476
[TBL] [Abstract][Full Text] [Related]
12. PTH replacement therapy of hypoparathyroidism.
Rejnmark L; Sikjaer T; Underbjerg L; Mosekilde L
Osteoporos Int; 2013 May; 24(5):1529-36. PubMed ID: 23184178
[TBL] [Abstract][Full Text] [Related]
13. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
[TBL] [Abstract][Full Text] [Related]
14. Skeletal Manifestations of Hypoparathyroidism.
Rubin MR
Bone; 2019 Mar; 120():548-555. PubMed ID: 30465918
[TBL] [Abstract][Full Text] [Related]
15. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
Gafni RI; Brahim JS; Andreopoulou P; Bhattacharyya N; Kelly MH; Brillante BA; Reynolds JC; Zhou H; Dempster DW; Collins MT
J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
[TBL] [Abstract][Full Text] [Related]
16. Effects of Parathyroid Hormone Administration on Bone Strength in Hypoparathyroidism.
Rubin MR; Zwahlen A; Dempster DW; Zhou H; Cusano NE; Zhang C; Müller R; Bilezikian JP
J Bone Miner Res; 2016 May; 31(5):1082-8. PubMed ID: 26724790
[TBL] [Abstract][Full Text] [Related]
17. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis.
Liu XX; Zhu XY; Mei GH
Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.
Kruse K; Kracht U; Wohlfart K; Kruse U
Eur J Pediatr; 1989 Apr; 148(6):535-9. PubMed ID: 2744015
[TBL] [Abstract][Full Text] [Related]
20. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
Walker Harris V; Jan De Beur S
Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
